Position in ANIK
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$369,919
+$114,777 QoQ
Shares Held
25,285
+43.7% QoQ
Ownership
0.189%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 134 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 11%
Shared 0%
None 89%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $43,567,425 across 30 Drug Manufacturers - Specialty & Generic names. ANIK ranks #18 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
56,839 | $9,579,645 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
16,741 | $9,070,776 | |
| 3 | ZTS |
Zoetis Inc.
|
66,412 | $4,772,366 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
167,856 | $2,690,731 | |
| 5 | VTRS |
Viatris Inc
|
160,652 | $2,551,153 | |
| 6 | HLN |
Haleon plc
|
259,261 | $2,418,905 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
70,403 | $2,385,253 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
74,362 | $1,830,048 |
All Filings in ANIK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $369,919 | 25,285 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $255,142 | 17,596 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $122,479 | 12,745 | Shares | Sole | 2026-02-18 | |
| No filing history on record for this holder in this stock. | ||||||